Rising health care costs and life-cycle management in the pharmaceutical market.
Aaron S Kesselheim
PLoS Medicine · 2013
doi:10.1371/journal.pmed.1001461 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
: Aaron Kesselheim discusses Natalie Vernaz and colleagues' paper on the effects on health care costs of “evergreening” strategies pursued by drug manufacturers.
Abstract licence: CC BY
References7
7 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.